Rubén Prieto-Díaz

7PUBLICATIONS
29CO-AUTHORS
Biologically active moleculesBiomolecular modelling and designCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 12, 2025
Conformational Restriction of Designer Drugs Reveals Subtype-Selective and Biased CB2 Agonists with Neuroprotective Effects.

Claudia Gioé-Gallo, Sandra Ortigueira, Rubén Prieto-Díaz

|Apr 13, 2023
Multicomponent Reaction-Assisted Drug Discovery: A Time- and Cost-Effective Green Approach Speeding Up Identification and Optimization of Anticancer Drugs.

Giovanni Graziano, Angela Stefanachi, Marialessandra Contino

|Dec 14, 2022
Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists.

Rubén Prieto-Díaz, Manuel González-Gómez, Hugo Fojo-Carballo

|Feb 18, 2022
Exploring Non-orthosteric Interactions with a Series of Potent and Selective A3 Antagonists.

Darío Miranda-Pastoriza, Rodrigo Bernárdez, Jhonny Azuaje

|Jan 24, 2022
Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A1 Antagonists.

Cristina Val, Carlos Rodríguez-García, Rubén Prieto-Díaz

Pageof 2